Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV Platform at Virtual R&D Day Today

    NEXT STORY
    Genmab to Host Capital Markets Day
    PREV STORY
    OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Cara Therapeutics Reports Second Quarter 2018 Financial Results

    – Conference call today at 4:30 p.m. ET –STAMFORD, Conn., Aug. 07, 2018 (GLOBE ...

    author_avatar
    NASDAQ Market News

    Invuity Announces Closing of Public Offering of Common Stock and Underwriters’ Full Exercise of Option to Purchase Additional Shares

    SAN FRANCISCO, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the ...

    author_avatar
    NASDAQ Market News

    Stemline Therapeutics Announces Validation of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA)

    NEW YORK, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a ...

    author_avatar
    NASDAQ Market News